
Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
Oncology Today with Dr Neil Love
00:00
Dose Reduction and Management Strategies
Panel discusses holding drug, dose reductions, and using SGLT2 or GLP-1 agents to manage PI3K/AKT hyperglycemia.
Play episode from 33:25
Transcript


